tiprankstipranks
Trending News
More News >
Edwards Lifesciences (EW)
NYSE:EW
US Market

Edwards Lifesciences (EW) Income Statement

Compare
1,940 Followers

Edwards Lifesciences Income Statement

Last quarter (Q4 2025), Edwards Lifesciences's total revenue was $1.57B, an increase of 13.26% from the same quarter last year. In Q4, Edwards Lifesciences's net income was $91.20M. See Edwards Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 6.07B$ 5.44B$ 5.01B$ 5.38B$ 5.23B
Gross Profit
$ 4.74B$ 4.32B$ 3.97B$ 4.22B$ 4.01B
Operating Expenses
$ 3.10B$ 2.94B$ 2.55B$ 2.51B$ 2.40B
Depreciation and Amortization
$ 156.60M$ 155.20M$ 144.90M$ 166.80M$ 163.30M
EBITDA
$ 1.43B$ 1.72B$ 1.53B$ 1.96B$ 1.89B
Operating Income
$ 1.64B$ 1.38B$ 1.43B$ 1.70B$ 1.61B
Other Income/Expenses
$ -363.30M$ 169.40M$ -54.90M$ 65.00M$ 91.60M
Pretax Income
$ 1.27B$ 1.55B$ 1.37B$ 1.77B$ 1.70B
Net Income
$ 1.07B$ 4.17B$ 1.40B$ 1.52B$ 1.50B
Per Share Metrics
Basic EPS
$ 1.84$ 6.98$ 2.31$ 2.46$ 2.41
Diluted EPS
$ 1.83$ 6.97$ 2.30$ 2.44$ 2.38
Weighted Average Shares Outstanding
584.80M 597.70M 606.70M 619.00M 623.30M
Weighted Average Shares Outstanding (Diluted)
585.80M 599.30M 609.40M 624.20M 631.20M
Currency in USD

Edwards Lifesciences Earnings and Revenue History